NeurologyLive® Friday 5 — September 6, 2024
NeurologyLive's Friday 5 highlights: 1) Sharon Cohen on mivelsiran for early-stage Alzheimer disease; 2) Aliza Alter on BHV-7000 for focal epilepsy; 3) Jim Cassidy on mirdametinib for neurofibromatosis type 1; 4) Crystal Proud on SMA research and treatments; 5) Michael Levy on ravulizumab for NMOSD.
Highlighted Terms
Related News
NeurologyLive® Friday 5 — September 6, 2024
NeurologyLive's Friday 5 highlights: 1) Sharon Cohen on mivelsiran for early-stage Alzheimer disease; 2) Aliza Alter on BHV-7000 for focal epilepsy; 3) Jim Cassidy on mirdametinib for neurofibromatosis type 1; 4) Crystal Proud on SMA research and treatments; 5) Michael Levy on ravulizumab for NMOSD.